Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-769-9 | CAS number: 858956-08-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity (OECD 401, GLP), mice: LD50 > 5000 mg/kg bw
Acute inhalation toxicity (OECD 403, GLP), rat: LC50 > 5.4 mg/L
Acute dermal toxicity (OECD 402, GLP), rat: LD50 > 5000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 March - 7 June 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Version / remarks:
- Adopted: 2001
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina, USA
- Age at study initiation: 10 - 11 weeks
- Weight at study initiation: 227.1, 231.8 and 251.0 g
- Fasting period before study: approximately 16-18 h
- Housing: individually in stainless steel, wire-mesh cages suspended above cage boards
- Diet: PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002, ad libitum
- Water: ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 26
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- other: water (deionized)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw
CLASS METHOD
- Rationale for the selection of the starting dose: according to EPA OPPTS 870.1100 - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 3 (The rats were dosed one at a time at a minimum of 48 h intervals.)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observation for mortality and signs of illness, injury, or abnormal behavior, clinical signs were observed at the beginning of fasting, before dosing (test day 0), once during the first 30 min after dosing and 2 more times on the day of dosing, and once daily thereafter body weight was determined on Day -1, 0, 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities were observed.
- Clinical signs:
- other: One rat exhibites diarrhea on the day after dosing. No clinical signs of toxicity were observed in the remaining two rats.
- Gross pathology:
- Animals sacrificed at the end of the post-treatment observation period showed no evidence of gross lesions.
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In this acute oral toxicity study in female rats a LD50 value of > 5000 mg/kg bw was determined.
Reference
Table 1. Table for acute oral toxicity.
Dose |
Toxicological results* |
Duration of clinical signs |
Time of death |
Mortality (%) |
Females |
||||
5000 |
0/1/3 |
Day 1 postdosing |
--- |
0 |
LD50> 5000 mg/kg bw |
||||
* first number = number of dead animals |
||||
second number = number of animals with clinical signs |
||||
third number = number of animals used |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises an adequate, reliable (Klimisch score 1) and consistent study, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 March - 01 June 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- adopted 12 May 1981
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- traditional method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina, USA
- Age at study initiation: approximately 8 weeks (males and females)
- Weight at study initiation: 249 - 270 g (males), 181 - 197 g (females)
- Housing: individually in stainless steel, wire-mesh cages suspended above cage boards
- Diet: PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002, ad libitum
- Water: ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 26
- Humidity (%): 30 - 70
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 3.5 µm
- Geometric standard deviation (GSD):
- 1.9
- Remark on MMAD/GSD:
- Particle size distribution:
2.2 - 2.5 % of aerosols: less than 1 µm MMAD
37 - 49 % of aerosols: less than 3 µm MMAD
86 - 87 % of aerosols: less than 10 µm MMAD - Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: glass (cylindrical) exposure chamber
- Exposure chamber volume: 36 L
- Method of holding animals in test chamber: Animals were individually restrained in perforated stainless steel cylinders with conical nose pieces. The restrainers were inserted into a polymethylmethacrylate faceplate attached to the exposure chamber so that the nose of each animal extended into the exposure chamber.
- Source and rate of air: house air
- Method of conditioning air: The chamber atmosphere was generated by suspension of the test substance in air with a Fluid Energy Processing model 00 Jet-O-Mizer.
- System of generating particulates/aerosols: The test substance was metered into the jetmill with a K-Tron model T-20 Twin Screw volumetric feeder. Filtered, high-pressure air, metered into the jetmill, carried the resulting atmosphere through a 1-L glass cyclone and into the exposure chamber. Chamber concentrations of test substance were controlled by varying the test substance feed rate to the jetmill.
- Method of particle size determination: Sierra® series 210 cyclone preseparator/cascade impactor and Sierra® series 110 constant flow air sampler
- Treatment of exhaust air: The test atmosphere was exhausted through a high-capacity canister filter prior to discharge into the fume hood.
- Temperature, humidity, airflow range, oxygen concentration: 20-22°C, 45-49%, 20 L/min (34 air changes/h), 21%
TEST ATMOSPHERE
- Brief description of analytical method used: gravimetric analysis. The known volumes of chamber atmosphere were drawn from the sampling port through a 25 mm filter cassette containing a pre-weighed glass fiber (Type A/E) filter. The filters were weighed on a Cahn model C-30 Microbalance®. The atmospheric concentration of the test substance was calculated from the difference between the pre- and post-sampling filter weights divided by the volume of chamber atmosphere sampled. High performance liquid chromatography (HPLC) analysis was used to determine the percentage of active ingredient on the gravimetric filters. HPLC analysis showed that the mean DPX-MAT28 content on the filters was 90% of the collected mean gravimetric mass (8.6 g vs. 9.6 g). The average recovery of DPX-MAT28 active ingredient was 98%.
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle: air
TEST ATMOSPHERE
- Particle size distribution: 2.2 - 2.5 % of aerosols: less than 1 µm MMAD, 37 - 49 % of aerosols: less than 3 µm MMAD, 86 - 87 % of aerosols: less than 10 µm MMAD
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 3.5 μm ± 1.9
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Air samples were collected at 3 separate locations (faceplate) and at the reference port. All samples (faceplate) were within 20% of the overall mean and were homogenously distributed. Difference between faceplate measurements and reference port was <1%.
- Duration of exposure:
- 4 h
- Concentrations:
- 5.4 ± 0.9 mg/L (mean ± standard deviation)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily for clinical signs and mortality, body weight at days 0, 1, 2, 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight other: gross pathology examination included observation of the nasal passages - Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.4 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortalities were observed.
- Clinical signs:
- other:
- Body weight:
- One day following exposure to the test substance, a slight, reduction in mean body weight was observed in males, but not in females. By post-exposure day 2, all rats gained body weight.
- Gross pathology:
- Animals sacrificed at the end of the post-treatment observation period showed no evidence of gross lesions.
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In this acute inhalation toxicity study in rats a LC50 value of > 5.4 mg/L air was determined.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises an adequate, reliable (Klimisch score 1) and consistent study, and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07 March - 17 May 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted (according to study report) 1987
- Deviations:
- yes
- Remarks:
- Limit dose higher than 2000 mg/kg bw/day (5000 mg/kg bw/day)
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina, USA
- Females nulliparous and non-pregnant: not specified
- Age at study initiation: approximately 9 weeks (males), 10 weeks (females)
- Weight at study initiation: 290.2 g (males), 225.5 g (females)
- Housing: individually in stainless steel, wire-mesh cages suspended above cage boards
- Diet: water, ad libitum
- Water: PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002, ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 -26
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: shaved back from the scapular to the lumbar region (approximately 5 cm x 7.4 cm, 37 cm²)
- Type of wrap if used: test substance was covered with a 2-ply gauze patch. Rats were then wrapped with stretch gauze bandage and self-adhesive bandage.
REMOVAL OF TEST SUBSTANCE
- Washing: warm water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount applied: 5000 mg/kg bw moistened with 0.6 mL of deionized water
- For solids, paste formed: yes
- Duration of exposure:
- 24 h
- Doses:
- 5000 mg/kg bw/day
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: mortality and clinical signs of illness, injury, dermal irritation and abnormal behavior were made daily (weekends excluded for dermal irritation). Body weight was determined prior to treatment and on days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight other: dermal irritation (Draize score) - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured during the 14 days test period.
- Clinical signs:
- other: No clinical signs of systemic toxicity were observed during the study period. Two male rats exhibited stained fur/skin or ocular discharge after test substance removal. These clinical signs are commonly seen in wrapped rats and therefore are not considere
- Gross pathology:
- Gross pathology did not reveal any abnormalities.
- Other findings:
- - Other observations: Erythema (score of 1 or 2) was observed in 9 rats and ulceration was observed in 4 rats on the day after application of the test substance. The erythema and ulceration may have been due to the gauze pads adhering to the test sites at the time of washing. No dermal irritation was observed in the remaining rat.
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In this acute dermal toxicity study a LD50 value of > 5000 mg/kg bw was determined in male and female rats.
Reference
Table 1. Table for acute dermal toxicity. | ||||
Dose [mg/kg bw] |
Toxicological results* | Duration of clinical signs | Time of death | Mortality (%) |
Males | ||||
5000 | 0/5/5 | stained (red) skin/fur chin, ulceration, black discharge eye bilateral, Day 1 | / | 0 |
Females | ||||
5000 | 0/1/5 | Hair loss (forelimb bilateral), Day 11 -14 | / | 0 |
LD50 = > 5000 mg/kg bw | ||||
* first number = number of dead animals | ||||
second number = number of animals with clinical signs | ||||
third number = number of animals used |
Table 1. Results of skin irritation parameters (Draize score) | ||||||||||||||||||||
Observation time | Rabbit no. | |||||||||||||||||||
1 (male) | 2 (male) | 3 (male) | 4 (male) | 5 (male) | 6 (female) | 7 (female) | 8 (female) | 9 (female) | 10 (female) | |||||||||||
Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | Erythema | Edema | |
1 Day | 0 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 2 | 0 |
Day 2-14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available information comprises an adequate, reliable (Klimisch score 1) and consistent study, and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Additional information
Acute oral toxicity
Acute toxicity of the test substance, dissolved in deionized water, was tested in Crl:CD(SD) rats according to OECD TG 425 and GLP (2011a). Groups of 3 female rats each were exposed to 5000 mg/kg bw (20 mL/kg bw) via gavage. No mortality was observed until the end of the observation period of 14 days. One rat exhibited diarrhea on the day after dosing. No clinical signs of toxicity were observed in the remaining two rats. No effects on body weight or body weight development and no gross pathological findings were identified. Thus, a LD50 > 5000 mg/kg bw was derived.
Acute inhalation toxicity
Acute inhalation toxicity was tested in Crl:CD(SD) rats according to OECD Guideline 403 and in compliance with GLP (2011b). 5 male and 5 female rats were exposed (nose only) to an aerosol (dust) of the test substance at an average concentration of 5.4 ± 1.9 mg/mL air for 4 h. The aerosol generated was of adequate respirability with a MMAD ca. 3.5 µm (GSD ca. 1.9 and MMAD of at least 87%<10 μm). After exposure, animals were examined for a period of 14 days. Examinations included daily observation of clinical signs, determination of body weights and gross pathology examination. No mortalities were observed during the observation period. One female rat had discharge from the eyes on the day of exposure (day 0) and 3 males and 2 females demonstrated stained skin/fur on days 0 and 1. These signs disappeared and the rats were normal by 2 days post-exposure. Body weights in males were slightly reduced one day following exposure to the test substance. However, 2 days post-exposure all rats gained body weight. No effect on body weight was observed in females. Gross pathology analyses did not reveal any abnormalities. No test substance related mortality was observed, thus a median lethal concentration (LC50, aerosol, 4 h) of > 5.4 mg/L was determined for both sexes.
Acute dermal toxicity
Acute dermal toxicity of the test substance was tested in Crl:CD(SD) rats according to OECD Guideline 402 and in compliance with GLP (2011c). Five rats per sex were exposed to the test substance moistened with 0.6 mL deionized water at a dose of 5000 mg/kg bw (5 cm x 7.4 cm, 37 cm²) under semi-occlusive conditions. After an exposure period of 24 h the test substance was removed with warm water. Subsequently animals were examined for a period of 14 days. Examinations included daily clinical observations and determination of body weights prior to treatment (days 0) and at days 7 and 14. At the end of the observation period, gross pathology was performed. Two male rats exhibited stained fur/skin or ocular discharge after test substance removal. These clinical signs are commonly seen in wrapped rats and therefore are not considered as test substance related. Hair loss observed in 1 female rat was considered incidental. No further clinical signs of systemic toxicity were observed at the maximum dose of 5000 mg/kg bw. Effects on body weight were not observed and gross pathology examinations did not reveal test-substance-related grossly visible organ lesions. None of the exposed rats died, thus a dermal LD50 of >5000 mg/kg bw was determined for both males and females.
Overall conclusion
In summary, the available data on acute toxicity following oral, dermal and inhalation exposure consistently indicate a very low level of acute toxicity in rats. Therefore the test substance is not considered as hazardous after acute exposure.
Justification for classification or non-classification
The available data on the test substance for acute toxicity following oral, dermal and inhalation exposure do not meet the criteria for classification according to Regulation (EC) No. 1272/2008. Data are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.